Mesoblast Limited
Level 1, 843A Glenhuntly Road
Caulfield South
VIC
3162
Tel: 03-9618-7000
305 articles about Mesoblast Limited
-
Mesoblast Limited Proprietary Stem Cells Successfully Repair/Regenerate Damaged Intervertebral Disc Cartilage
9/10/2009
-
Mesoblast Limited Interview With MD Silviu Itescu On Angioblast - Progression of Four Phase 2 Trial Applications
9/1/2009
-
Mesoblast Limited US Associate Company Angioblast Closes A$10 Million Equity-Based Financing
8/25/2009
-
Mesoblast Limited Associate Company Angioblast Systems Secures New Capital
8/19/2009
-
Mesoblast Limited Gains US FDA Clearance For Phase 2 Trial Of NeoFuse In Minimally Invasive Lumbar Spinal Fusion Surgery
8/17/2009
-
Mesoblast Limited World-First Allogeneic Stem Cell Trial For Treatment Of End-Stage Heart Failure Patients
8/7/2009
-
Mesoblast Limited Letter To Shareholders From Chairman, Brian Jamieson
7/30/2009
-
Mesoblast Limited In Strong Cash Position At End Of Financial Year
7/30/2009
-
Mesoblast Limited Applies For Regulatory Approval Of Its Bone Fracture Repair Products
7/23/2009
-
Mesoblast Limited First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment
6/24/2009
-
Mesoblast Limited Chairman's Letter to Shareholders
5/5/2009
-
Mesoblast Limited Commences Clinical Program For Fusion Of Cervical Spine
4/28/2009
-
Mesoblast Limited Completes Equity Raising For Clinical Programs
4/1/2009
-
Mesoblast Limited Raises Capital Of A$10.81 Million For New Clinical Programs
3/30/2009
-
Mesoblast Limited Presents Positive Adult Stem Cell Results To American Academy of Orthopaedic Surgeons
2/27/2009
-
Mesoblast Limited Emerging Portfolio of Clinical Products Underpin Commercial Strategic Objectives
2/26/2009
-
Mesoblast Limited First Group Of Heart Failure Patients Treated With "Off-The-Shelf" Adult Stem Cells Successfully Pass Key Safety Milestone
2/25/2009
-
Mesoblast Limited To Provide Cutting Edge Treatment Using Proprietary Adult Stem Cell Products
2/17/2009
-
Mesoblast Limited Stem Cells Approved For World First Osteoathritis Clinical Trial
1/20/2009
-
Mesoblast Limited Named 2009 North American Emerging Company By Frost & Sullivan
1/6/2009